mifepristone has been researched along with megestrol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bons, EG; Lamberts, SW; Uitterlinden, P; Verleun, T | 1 |
| Bakker, GH; de Jong, FH; Henkelman, MS; Klijn, JG; Lamberts, SW; Setyono-Han, B; van der Schoot, P | 1 |
| Lamberts, SW; van Koetsveld, P; Verleun, T | 1 |
| Croxatto, HB; Fuentealba, B; Massai, R; Salvatierra, AM | 1 |
| Cao, L; Gu, ZP; Leng, Y; Yang, B | 1 |
| Baldacci, C; Caruso, A; Fornari, L; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Mannella, P; Scorticati, C; Simoncini, T | 1 |
| Boesch, C; Bronner, C; Hecker, M; Jourdain, M; Schini-Kerth, VB; Zerr-Fouineau, M | 1 |
1 review(s) available for mifepristone and megestrol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for mifepristone and megestrol
| Article | Year |
|---|---|
Contraceptive potential of a mifepristone-nomegestrol acetate sequential regimen in women.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Luteinizing Hormone; Megestrol; Menstruation-Inducing Agents; Mifepristone; Norpregnadienes; Ovulation; Progesterone; Progesterone Congeners; Sterilization, Reproductive | 1998 |
6 other study(ies) available for mifepristone and megestrol
| Article | Year |
|---|---|
Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Animals; Body Weight; Cells, Cultured; Estrenes; Female; Megestrol; Megestrol Acetate; Mifepristone; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid | 1985 |
Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Topics: Animals; Body Weight; Buserelin; Combined Modality Therapy; Estrenes; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mifepristone; Ovariectomy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1987 |
Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Topics: Animals; Cells, Cultured; Dexamethasone; Estradiol; Estrenes; Megestrol; Megestrol Acetate; Mifepristone; Pituitary Neoplasms; Progesterone; Prolactin; Rats; Rats, Inbred BUF; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Tamoxifen | 1987 |
Effects of anordrin, droloxifene, nomegestrol, and mifepristone on cultured rat luteal cell apoptosis.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Contraceptives, Oral, Synthetic; Corpus Luteum; Estrogen Antagonists; Female; Luteolytic Agents; Megestrol; Mifepristone; Norandrostanes; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Tamoxifen | 1999 |
Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate.
Topics: Cells, Cultured; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelial Cells; Estradiol; Humans; Medroxyprogesterone Acetate; Megestrol; Mifepristone; Nitric Oxide; Nitric Oxide Synthase; Norpregnadienes; Progesterone; Progesterone Congeners; Signal Transduction | 2006 |
Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.
Topics: Blood Platelets; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; GTP Cyclohydrolase; Hormone Antagonists; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type III; Norpregnadienes; Platelet Aggregation; Progesterone; Progesterone Congeners; Pterins; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Thrombosis; Time Factors | 2009 |